Comparison of the Quality of Recovery After Cesarean Section Surgery

Sponsor
Muğla Sıtkı Koçman University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05999981
Collaborator
(none)
80
1
2
2.3
34.8

Study Details

Study Description

Brief Summary

Inadequate pain control after cesarean section surgery causes postpartum depression, persistent pain and delayed mother-infant bonding. The investigator's aim is to asses whether ultrasound guided transversalis fascia plane block (TFPB) or transversus abdominis plane (TAP) block would improve postoperative quality of recovery and decrease postoperative opioid consumption after cesarean section surgery.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Transversalis Fascia Plane Block
  • Procedure: Transversus Abdominis Plane Block
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Comparison Between Ultrasound Guided Transversalis Fascia Plane Block and Transversus Abdominis Plane Block on Postoperative Recovery in Patients Undergoing Cesarean Section Surgery
Anticipated Study Start Date :
Aug 24, 2023
Anticipated Primary Completion Date :
Nov 1, 2023
Anticipated Study Completion Date :
Nov 2, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Transversalis Fascia Plane Block (TFPB) Group

At TFPB group, the block will be performed by ultrasound guidance after completion of surgery. TFPB will be performed under ultrasonography guidance using a linear 6 to 13 megahertz ultrasound probe by the anesthesiologist. In TFPB group patients will receive 40 ml %0.25 bupivacaine divided into 2 equal doses between transversus abdominis muscle and transversalis fascia bilaterally.

Procedure: Transversalis Fascia Plane Block
40 ml %0.25 bupivacaine divided into 2 equal doses will be injected by the anesthesiologist under ultrasonography guidance between transversus abdominis muscle and transversalis fascia bilaterally

Active Comparator: Transversus Abdominis Plane (TAP) Block Group

At TAP block group, the block will be performed by ultrasound guidance after completion of surgery. TAP blocks will be performed under ultrasonography guidance using a linear 6 to 13 megahertz ultrasound probe by the anesthesiologist. In TAP block group patients will receive 40 ml %0.25 bupivacaine divided into 2 equal doses in the fascial plane between internal oblique muscle and transversus abdominis muscle bilaterally.

Procedure: Transversus Abdominis Plane Block
40 ml %0.25 bupivacaine divided into 2 equal doses will be injected by the anesthesiologist under ultrasonography guidance in the fascial plane between internal oblique muscle and transversus abdominis muscle bilaterally

Outcome Measures

Primary Outcome Measures

  1. Postoperative quality of recovery [Postoperative 24th hour]

    Postoperative quality of recovery will be assessed by Obstetric Quality of Recovery 11 Turkish (ObsQoR-11T) score

Secondary Outcome Measures

  1. Postoperative opioid consumption [Postoperative 1st, 2nd, 4th, 8th 12th and 24th hour]

    Morphine consumption will be assessed by checking patient controlled analgesia (PCA) device records and fentanyl consumption will be assessed by checking patient daily drug order records

  2. Numeric Rating Scale [Postoperative 1st, 2nd, 4th, 8th 12th and 24th hour]

    A blinded nurse will assess postoperative pain during resting and movement at postoperative 1st, 2nd, 4th, 8th 12th and 24th hour by using 11-point Numerical Rating Scale which ranges from '0' (means no pain) to '10' (means worst pain imaginable)

  3. Adverse Reactions [Postoperative 24th hour]

    Nausea, vomiting, constipation, urinary retention and skin rash/pruritus will be assessed

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • American Society of Anesthesiologists physical status II-III

  • Cesarean section surgery under spinal anesthesia

Exclusion Criteria:
  • American Society of Anesthesiologists physical status IV

  • Emergency surgery

  • General anesthesia

  • Additional surgical intervention at the same session

  • Body mass index of more than 35 kg/m2

  • Allergy to any study drugs

  • Local infection at the injection site

  • History of drug abuse

  • Communication problem

  • Coagulopathy

  • Preeclampsia and eclampsia

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mugla Sıtkı Kocman University Training and Research Hospital Mugla Turkey

Sponsors and Collaborators

  • Muğla Sıtkı Koçman University

Investigators

  • Principal Investigator: Melike Korkmaz Toker, Associate Professor, Mugla Sıtkı Kocman University Department of Anesthesiology and Reanimation

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Melike Korkmaz Toker, Associate Professor, Muğla Sıtkı Koçman University
ClinicalTrials.gov Identifier:
NCT05999981
Other Study ID Numbers:
  • MSKU 13-IV
First Posted:
Aug 21, 2023
Last Update Posted:
Aug 22, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Melike Korkmaz Toker, Associate Professor, Muğla Sıtkı Koçman University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 22, 2023